EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC-ND 4.0

Vitreous transforming growth factor-beta 2 levels predicted the risk of proliferative vitreoretinopathy in rhegmatogenous retinal detachment: A cross-sectional study

Lailatul Rizkah, Dewi Fathin Romdhoniyyah, Neilil Muna Mufidana, H Khairunnissaa Qonitatun, Dinda Mutiara Maharani, Aurelia Priscilla Regita Putri, Vera Nurohmah Indrawati, Ummi Noor Hasanah, Handayani, Mohammad Eko Prayogo, Firman Setya Wardhana, Muhammad Bayu Sasongko und 4 weitere

Journal of Clinical Ophthalmology and Research · 2026-10 · 14 (4) · 400-405

DOI: 10.4103/jcor.jcor_158_26 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Journal of Clinical Ophthalmology and Research, online erschienen am 18.11.2026. Verfasst von Lailatul Rizkah und 15 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Transforming growth factor-beta 2 (TGF-β2) drives fibrotic pathways and epithelial-mesenchymal transition in proliferative vitreoretinopathy (PVR). This study aimed to evaluate vitreous TGF-β2 levels as a potential biomarker for PVR risk in patients with rhegmatogenous retinal detachment (RRD).

Methods

A cross-sectional study was conducted at three tertiary eye centres in Yogyakarta, Indonesia, between July and December 2024. Thirty-six adult patients with RRD undergoing pars plana vitrectomy were enrolled, comprising 13 with PVR and 23 without PVR. Undiluted vitreous humour samples were collected at the onset of surgery and analysed for TGF-β2 concentration using a commercial ELISA kit. Demographic and clinical characteristics were recorded. Statistical analysis compared TGF-β2 levels between groups, evaluated diagnostic performance using receiver operating characteristic (ROC) curve analysis, and assessed PVR risk using logistic regression of TGF-β2 tertiles.

Results

Baseline demographic and clinical characteristics were comparable between groups. The median vitreous TGF-β2 level was significantly higher in the PVR group (3774.6 pg/ml, IQR 3247.3–7147.3) than in the non-PVR group (2701.8 pg/ml, IQR 2220.0–3992.7; p=0.011). ROC analysis showed an area under the curve of 0.74 (95% CI 0.553–0.925; p=0.022), with an optimal cut-off of 2770 pg/ml. Logistic regression revealed a significant dose-response relationship: patients in the highest TGF-β2 tertile had 12.83 times higher odds of PVR (95% CI 1.26–130.51; p=0.031) compared with the lowest tertile.

Conclusions

Elevated vitreous TGF-β2 levels are significantly associated with PVR in patients with RRD, supporting its role as a key pathogenic mediator and a potential biomarker for PVR risk stratification.

Zitieren

APA

Rizkah, L., Romdhoniyyah, D. F., Mufidana, N. M., Qonitatun, H. K., Maharani, D. M., Putri, A. P. R., Indrawati, V. N., Hasanah, U. N., Handayani, Prayogo, M. E., Wardhana, F. S., Sasongko, M. B., Mahayana, I. T., Utomo, P. T., Supanji, & Darajati, I. T. (2026). Vitreous transforming growth factor-beta 2 levels predicted the risk of proliferative vitreoretinopathy in rhegmatogenous retinal detachment: A cross-sectional study. Journal of Clinical Ophthalmology and Research, 14(4), 400-405. https://doi.org/10.4103/jcor.jcor_158_26

Vancouver

Rizkah L, Romdhoniyyah DF, Mufidana NM, Qonitatun HK, Maharani DM, Putri APR, et al. Vitreous transforming growth factor-beta 2 levels predicted the risk of proliferative vitreoretinopathy in rhegmatogenous retinal detachment: A cross-sectional study. Journal of Clinical Ophthalmology and Research. 2026;14(4):400-405. doi:10.4103/jcor.jcor_158_26

BibTeX
@article{Rizkah2026,
  author = {Rizkah, Lailatul and Romdhoniyyah, Dewi Fathin and Mufidana, Neilil Muna and Qonitatun, H Khairunnissaa and Maharani, Dinda Mutiara and Putri, Aurelia Priscilla Regita and Indrawati, Vera Nurohmah and Hasanah, Ummi Noor and Handayani and Prayogo, Mohammad Eko and Wardhana, Firman Setya and Sasongko, Muhammad Bayu and Mahayana, Indra Tri and Utomo, Purjanto Tepo and Supanji and Darajati, Irene Titin},
  title = {Vitreous transforming growth factor-beta 2 levels predicted the risk of proliferative vitreoretinopathy in rhegmatogenous retinal detachment: A cross-sectional study},
  journal = {Journal of Clinical Ophthalmology and Research},
  year = {2026},
  volume = {14},
  number = {4},
  pages = {400--405},
  doi = {10.4103/jcor.jcor_158_26}
}
Kostenlos starten →